Literature DB >> 24055400

miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).

Wu Yungang1, Li Xiaoyu2, Taizhong Pang2, Li Wenming3, Xinliang Pan4.   

Abstract

microRNAs, a family of small non-coding RNAs, involve in the pathogenesis of several types of cancers, including laryngeal squamous cell carcinoma (LSCC). MiR-370 is frequently aberrant expressed in various types of human cancer including LSCC. However, the role for miR-370 in LSCC remains elusive. Here, we demonstrate that miR-370 was down-regulated in human LSCC tissues. Furthermore, there was an inverse relationship between Forkhead Box ml (FoxM1), which was up-regulated and miR-370 expression in LSCC tissues. FoxM1 was subsequently predicted by bioinformatics and verified to be a target of miR-370 by Luciferase reporter assay. Restored expression of miR-370 in Hep2 cells significantly inhibited cell proliferation. In conclusion, our results suggest that miR-370 may function as a tumor suppressor in LSCC through downregulation of FoxM1, suggesting that miR-370 could serve as a novel potential maker for LSCC therapy.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell proliferation; FoxM1; Laryngeal squamous cell carcinoma; MiR-370

Mesh:

Substances:

Year:  2013        PMID: 24055400     DOI: 10.1016/j.biopha.2013.08.008

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  33 in total

1.  Physcion induces apoptosis in hepatocellular carcinoma by modulating miR-370.

Authors:  Xiaoping Pan; Haixia Wang; Dongmeng Tong; Chen Wang; Li Sun; Chunjuan Zhao; Yan Li; Lida Zhu; Di Wu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling.

Authors:  Yantao Han; Xiuwei Yang; Ning Zhao; Jianjun Peng; Hui Gao; Xia Qiu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

3.  LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.

Authors:  Qingjun Yang; Jin Sun; Yifei Ma; Chunjie Zhao; Jijun Song
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

4.  CCAT1 promotes laryngeal squamous cell carcinoma cell proliferation and invasion.

Authors:  Kun Zhuang; Qiang Wu; Senhe Jiang; Huijun Yuan; Shaomin Huang; Huijun Li
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1.

Authors:  Wensheng Ge; Chaodong Han; Jing Wang; Yunping Zhang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

6.  The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies.

Authors:  Agnieszka Piechowska; Celina Kruszniewska-Rajs; Magdalena Kimsa-Dudek; Magdalena Kołomańska; Barbara Strzałka-Mrozik; Joanna Gola; Stanisław Głuszek
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-15       Impact factor: 4.553

7.  MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.

Authors:  Ning Duan; Xiaojing Hu; Xiaowei Yang; Huiguang Cheng; Wentao Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 8.  MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy.

Authors:  Pei Li; Hui Liu; Zhiyuan Wang; Feng He; Haifeng Wang; Zhi Shi; Ankui Yang; Jin Ye
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

9.  Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.

Authors:  Xiaofei Lin; Zhengyan Wang; Yumei Wang; Weijing Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Hsa_circ_0042823 accelerates cancer progression via miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma.

Authors:  Tianyi Wu; Yanan Sun; Zhanwei Sun; Shichao Li; Weiwei Wang; Boyu Yu; Guangke Wang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.